JP Labs Blog · Quality & Testing

What a Peptide COA Actually Shows: HPLC, LC-MS, and Why Purity Testing Matters

A Certificate of Analysis (COA) is the single most important document accompanying any research peptide, yet many researchers never learn to read one beyond checking for a passing percentage. Understanding what HPLC and LC-MS data actually represent — and what they cannot tell you — is essential for designing reproducible in vitro experiments and interpreting anomalous results.

Research Use Only. All information on this page is for educational and research reference purposes. JP Labs products are intended strictly for in vitro laboratory research. Not for human or veterinary use. Not FDA approved for any therapeutic purpose.

What Is a COA?

A Certificate of Analysis is a laboratory-generated document that reports the analytical testing results for a specific batch (lot) of research material. For peptides, a proper COA is not a marketing sheet — it is a compilation of instrumental data generated by chromatography and spectrometry equipment, typically performed by an independent third-party analytical lab rather than the peptide manufacturer itself. A COA should always be batch-specific, meaning the data corresponds to the exact lot number printed on the vial in front of you, not a generic reference document reused across production runs.

At minimum, a research-grade COA should report purity by HPLC, identity confirmation by mass spectrometry, and often supplementary data such as residual solvent content, moisture content, and counter-ion analysis (e.g., acetate or TFA content). Anything less than this is an incomplete picture of what is actually in the vial.

HPLC: Measuring Purity

High-Performance Liquid Chromatography (HPLC) separates the components of a sample based on how they interact with a stationary phase (the column packing) versus a mobile phase (the solvent gradient). As the sample is pushed through the column under pressure, different molecules travel at different rates depending on their size, charge, and hydrophobicity, causing them to elute — exit the column — at different times.

A detector, typically measuring UV absorbance at 214 nm (a wavelength that peptide bonds absorb strongly), records each eluting compound as a peak on a chromatogram. The area under the main peak, expressed as a percentage of the total area under all peaks, is reported as the purity percentage. A chromatogram showing a single sharp, symmetrical peak at >98% area is the visual signature researchers look for; broad, split, or shouldered peaks, or multiple smaller peaks scattered across the trace, indicate degradation products, truncated synthesis byproducts, or diastereomers.

📋 What a Clean Chromatogram Looks Like
A high-quality synthesis of a peptide such as BPC-157 or CJC-1295 should present as one dominant, symmetrical peak occupying the vast majority of the total peak area, with only trace, well-separated minor peaks representing residual synthesis byproducts below 1-2% each.

LC-MS: Confirming Identity

HPLC alone tells you how pure a sample is relative to itself — it does not tell you what the molecule actually is. This is where Liquid Chromatography–Mass Spectrometry (LC-MS) becomes essential. LC-MS couples the same separation principle as HPLC with a mass spectrometer detector that ionizes the eluting molecules and measures their mass-to-charge ratio (m/z).

The resulting mass spectrum should show a molecular ion mass that matches the theoretical calculated mass of the target peptide sequence within a very tight tolerance (typically within 0.1-0.5 Da for small peptides). This confirms identity — that the dominant peak observed in the chromatogram is actually the intended sequence, and not a coincidentally co-eluting contaminant of similar polarity. A sample could theoretically show a beautiful, sharp 99% HPLC peak that is entirely the wrong molecule; LC-MS is the check that rules this out.

Purity without identity confirmation is an incomplete answer. A peak can be sharp and still be the wrong compound.
Analytical chemistry principle applied to peptide QC

How to Read a Real COA

A well-structured COA presents its data in a standardized way so that results can be cross-checked against the physical lot on hand. The table below outlines the core fields a researcher should verify before using material in any in vitro protocol.

Why Purity Matters in Research

In cell-based and biochemical assays, impurities are not simply inert filler — they can be truncated peptide fragments, deletion sequences, or oxidized variants that retain partial structural similarity to the target compound. These impurities may bind off-target receptors, generate confounding signal in binding or functional assays, or introduce batch-to-batch variability that makes results impossible to reproduce across labs. A researcher troubleshooting inconsistent dose-response data should always ask whether the material itself, rather than the biological system under study, is the variable introducing noise.

This is particularly relevant for compounds studied for their receptor-mediated activity, such as GLP-3R or PT-141 analogs, where even small structural impurities can behave as partial agonists or antagonists in a receptor binding assay, skewing EC50/IC50 calculations derived from in vitro testing.

Common Red Flags

Not every COA circulating online represents genuine, batch-matched testing. Recognizing shortcuts and misrepresentations is a core literacy skill for any lab sourcing peptides for research use.

⚠ Independent Verification
A COA is only as trustworthy as the lab that generated it. Third-party, ISO-accredited analytical testing carries far more weight than an internal document produced by the same entity selling the material, since it removes any incentive to overstate purity results.

Sourcing Verified Material

For laboratories running in vitro studies, sourcing decisions should be treated with the same rigor as protocol design. Requesting the batch-specific COA before purchase, confirming the lot number matches upon receipt, and retaining documentation for every reagent used are basic elements of good laboratory recordkeeping. Compounds like NAD+ and Glutathione are especially sensitive to degradation and oxidation, making current, batch-matched analytical data even more critical than for more stable synthetic peptides.

Ultimately, a COA is a research tool, not a formality. Learning to interpret the chromatogram and mass spectrum behind the reported percentage gives researchers a far more reliable basis for evaluating material quality than a purity number in isolation.

Frequently Asked Questions

What is the difference between HPLC purity and LC-MS identity testing?
HPLC purity measures the relative abundance of the main compound against all other detectable peaks in a sample, expressed as a percentage of total peak area. LC-MS confirms that the dominant peak is actually the intended peptide sequence by matching its measured molecular mass against the theoretical value. Both tests are complementary — purity without identity confirmation cannot rule out a well-separated but structurally incorrect compound.
What HPLC purity percentage is generally considered acceptable for research peptides?
Most research-grade peptides are expected to show HPLC purity of 98% or higher for standard research applications, though requirements can vary depending on the specific study design. Lower purity material may still be usable for some non-sensitive applications, but it introduces more variability into dose-response and binding assays. Researchers should always evaluate the reported purity relative to the sensitivity of their specific experimental protocol.
Can a COA be faked or reused across different batches?
Yes, this is a known issue in the research peptide supply chain, where a single COA document is sometimes reused across multiple unrelated lots or even different products entirely. Legitimate COAs are batch-specific and include a lot number that should be cross-checked against the physical vial label. Requesting current, lot-matched documentation directly from the supplier before purchase is the best safeguard against this.
Why does peptide purity matter if the material is only used in vitro?
Impurities such as truncated fragments or oxidized variants can retain partial structural similarity to the target peptide and interact with off-target receptors or assay components. This can introduce confounding signal into binding, functional, or cell-based assays and reduce reproducibility across experimental replicates. High-purity, identity-confirmed material helps ensure that observed effects in a study are attributable to the intended compound rather than co-eluting contaminants.
Regulatory Notice

None of the statements on this website have been reviewed or approved by the U.S. Food and Drug Administration. JP Labs products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. All products are sold strictly for in vitro laboratory research purposes. They are not for human or animal use of any kind. DiPerna Services, LLC d/b/a JP Labs is not a compounding pharmacy or outsourcing facility as defined under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.